ELAN - Elanco Animal Health Inc
24.44
-0.440 -1.800%
Share volume: 4,089,140
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$24.88
-0.44
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-07-2024 | 02-25-2025 | 05-07-2025 | 08-07-2025 | 11-05-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 14.019 B | 13.764 B | 13.283 B | 12.614 B | 12.941 B | 13.742 B | 13.551 B | 13.358 B | |
| Current Assets | 4.050 B | 4.011 B | 3.366 B | 3.215 B | 3.440 B | 3.614 B | 3.493 B | 3.458 B | |
| Inventories | 1.638 B | 1.611 B | 1.632 B | 1.574 B | 1.592 B | 1.670 B | 1.708 B | 1.737 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 345.000 M | 416.000 M | 490.000 M | 468.000 M | 487.000 M | 539.000 M | 505.000 M | 545.000 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 949.000 M | 949.000 M | 979.000 M | 993.000 M | 1.047 B | 1.357 B | 1.392 B | 1.409 B | |
| Other Assets | 9.020 B | 8.804 B | 8.938 B | 8.406 B | 8.454 B | 8.771 B | 8.666 B | 8.491 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 14.019 B | 13.764 B | 13.283 B | 12.614 B | 12.941 B | 13.742 B | 13.551 B | 13.358 B | |
| Total liabilities | 7.963 B | 7.822 B | 6.760 B | 6.518 B | 6.588 B | 6.967 B | 6.802 B | 6.811 B | |
| Total current liabilities | 1.232 B | 1.370 B | 1.321 B | 1.315 B | 1.269 B | 1.392 B | 1.455 B | 1.597 B | |
| Accounts Payable | 302.000 M | 291.000 M | 259.000 M | 296.000 M | 330.000 M | 368.000 M | 352.000 M | 368.000 M | |
| Other liabilities | 474.000 M | 465.000 M | 587.000 M | 302.000 M | 487.000 M | 638.000 M | 607.000 M | 427.000 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 5.727 B | 5.463 B | 4.313 B | 4.277 B | 4.351 B | 4.148 B | 3.962 B | 3.943 B | |
| Other liabilities | 474.000 M | 465.000 M | 587.000 M | 302.000 M | 487.000 M | 638.000 M | 607.000 M | 427.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.056 B | 5.942 B | 6.523 B | 6.096 B | 6.353 B | 6.775 B | 6.749 B | 6.547 B | |
| Common stock | 8.777 B | 8.790 B | 8.804 B | 8.817 B | 8.819 B | 8.839 B | 8.854 B | 8.870 B | |
| Retained earnings | -2.256 B | -2.306 B | -1.942 B | -1.950 B | -1.883 B | -1.872 B | -1.906 B | -2.182 B |